Comparison and Analysis of Blood Loss Formulas

Completed

• Conditions: Blood Loss

• Registration Number: NCT03516552
• Lead Sponsor: Hospital Clinic of Barcelona

Brief Summary

Although it has been pointed that estimates are significantly inexact and different from each other, the actual accuracy of them has not been properly investigated and compared.

Detailed Description

Not available

Study Timeline

• Study Start: 2018-01-01
• Study First Submitted: 2018-04-15
• Study First Submitted QC: 2018-04-24
• Study First Posted: 2018-05-04
• Primary Completion: 2018-07-30
• Study Completion: 2018-08-10
• Status Verified: 2019-08
• Last Update Submitted: 2019-08-05
• Last Update Posted: 2019-08-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Adults 18 - 90 yrs.

Exclusion Criteria

• Suspected or confirmed coagulopathy (including current treatment with anticoagulants or antiplatelet agents).
• Surgical blood loss volume < 200 ml.
• Requirement for surgical gauzes during surgery, including conversion to open surgical techniques.
• Transfusion of red blood cells (RBCs) during the perioperative period.
• Significant postoperative bleeding (> 50 ml in surgical drains) or any other type of significant blood loss.
• Fluid infusions or vasoactive drugs after the first 24 postoperative hours.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Differences on blood loss estimation.	72 hours.

Trial Locations

Locations (1)

Hospital Clinic de Barcelona; 🇪🇸 Barcelona, Spain